Christophe Meille

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Induced Pluripotent Stem Cells

Acute Myeloid Leukemia

Cross Sectional

Top Venues

CPT: pharmacometrics & systems pharmacology

Clinical cancer research : an official journal of the American Association for Cancer Research

The AAPS journal

This page only lists publications with an associated author ORCID identifier.

Publications

Mélanie Wilbaux, David Demanse, Yi Gu, Astrid Jullion, Andrea Myers, Vasiliki Katsanou, Christophe Meille
Contribution of machine learning to tumor growth inhibition modeling for hepatocellular carcinoma patients under Roblitinib (FGF401) drug treatment. CPT: pharmacometrics & systems pharmacology 11 (8) (2022)
Nelson Guerreiro, Astrid Jullion, Stephane Ferretti, Claire Fabre, Christophe Meille
Translational Modeling of Anticancer Efficacy to Predict Clinical Outcomes in a First-in-Human Phase 1 Study of MDM2 Inhibitor HDM201. The AAPS journal 23 (2) (2021)
Eytan M Stein, Daniel J DeAngelo, Jörg Chromik, Manik Chatterjee, Sebastian Bauer, Chia-Chi Lin, Cristina Suarez, Filip Yves Francine De Vos, Neeltje Steeghs, Philippe Alexandre Cassier, David Tai, Jean-Jacques Kiladjian, Noboru Yamamoto, Rogier Mous, Jordi Esteve, Hironobu Minami, Stéphane Ferretti, Nelson Guerreiro, Christophe Meille, Rajkumar Radhakrishnan, Bernard Pereira, Luisa Mariconti, Ensar Halilovic, Claire Fabre, Cecilia Carpio
Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)